Breast Implants Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 2.05 Billion |
| Market Size (2029) | USD 2.97 Billion |
| CAGR (2024 - 2029) | 7.77 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Breast Implant Market Analysis
The Breast Implant Market size is estimated at USD 2.05 billion in 2024, and is expected to reach USD 2.97 billion by 2029, growing at a CAGR of 7.77% during the forecast period (2024-2029).
Breast implants are becoming more popular in emerging and developing countries as women become more aware of body image and seek to enhance their appearance. A study published in August 2023 by the National Library of Medicine found that breast augmentation can have a positive impact on the sexual function of women with hypomania. Along with that, the growing desire among women for beauty-enhancing breast augmentation and reconstruction procedures is expected to contribute to market growth.
According to the International Society for Aesthetic Plastic Surgeons (ISAPS), approximately 2.2 million breast augmentation procedures were reported globally in 2022, representing a significant 29% increase compared to the procedures reported in 2021. This surge in procedures is expected to drive demand for breast implants, which are commonly used in these procedures.
The global rise in breast cancer cases is also a significant factor influencing market growth. According to GLOBOCAN 2022, 11.5% of the total cancers accounted for breast cancer, marking it as the third most common cancer type. The Australian Institute of Health and Welfare's 2024 report projected approximately 20,500 new cases of breast cancer in females for 2023, representing 28% of all female cancer diagnoses. In Australia, breast cancer ranks as the second most prevalent cancer among individuals aged 20 to 39 and 60 to 79 and as the leading cancer for those aged 40 to 59. The increasing number of breast cancers is likely to boost the requirement for breast implantation in the market, resulting in market growth over the forecast period.
Market players are consistently trying to develop better and more efficient solutions in order to extend the lifespan of existing products. This is being achieved through strategic initiatives like awareness campaigns about breast implants, product launches, collaborations, and mergers and acquisitions.
For example, in January 2024, CollPlant Biotechnologies initiated a pre-clinical trial aimed at evaluating commercial-sized, regenerative, 3D-bioprinted breast implants. According to the company, as of January 2024, no commercial products allow the regeneration of soft tissues, including breast tissue. The main objective of this trial is to collect data to support the optimization of implant design. The refined design is expected to be used in a pivotal study intended for discussions with the United States FDA. The development of advanced breast implants is expected to significantly contribute to the market's expansion.
Factors such as the increasing incidence of breast cancer and the proactive initiatives taken by companies in product development are projected to play a key role in driving the growth of the breast implant market throughout the forecast period. However, there are also notable obstacles to the market's growth, such as post-surgery complications, associated risks, and the significant cost involved.
Breast Implants Market Trends
Silicone Implant is Expected to Hold a Major Share in the Market Over the Forecast Period
Due to rising demand for silicone implants, the silicone segment is expected to dominate the market over the forecast period. These implants are silicone shells filled with a plastic gel (silicone) that resemble human fat because of viscosity and are used for breast augmentation or reconstruction. Compared to other types of implants, they feel like natural breast tissue, which is the primary reason they are preferred by most people seeking implants compared to different kinds. Silicone breast implants are approved for breast augmentation in women 22 or older and for breast reconstruction in women of any age by the United States Food and Drug Administration.
New technological advancements and improvements in the existing silicone breast implant products for breast augmentation and reconstruction are expected to boost the market's growth. For instance, in July 2023, Sientra launched its high-strength cohesive silicone gel breast implants in Canada. Distributed by Clarion Medical Technologies, Sientra is one of the first new silicone gel breast implant manufacturers to receive approval from Health Canada in nearly two decades.
Additionally, increasing companies' initiatives to expand their product reach across the globe is likely to increase market growth. For instance, in October 2023, GC Aesthetics, specializing in designing, manufacturing, and distributing silicone breast implants, and Bimini Health Tech reported a joint venture named OPALINE Aesthetics. This collaboration aims to enhance patient access to breast implant solutions by merging their respective portfolios. This move is expected to complement Bimini's existing Puregraft portfolio, which is renowned among plastic and reconstructive surgeons.
Thus, due to the high demand for silicone-based breast implants coupled with strategic initiatives such as joint ventures by the market players, the market is expected to grow during the forecast period.
North America is Expected to Dominate the Market Over the Forecast Period
North America holds a significant share of the breast implant market and is expected to show a similar trend over the forecast period. This is mainly due to the high demand for breast augmentation surgeries due to several regional entertainment industries and women's self-awareness. The United States is expected to hold the largest market for breast implants in North America during the forecast period.
The demand for cosmetic surgeries and procedures is notably high among women in the United States, driving market growth. For instance, breast augmentation ranked among the top five cosmetic surgical procedures in 2022, with 255.2 thousand surgeries in the country. Many surgeries took place in-office, followed by hospitals and free-standing surgicenters.
Additionally, the rising prevalence of breast cancer in North America will contribute to market growth. In 2024, the American Cancer Society estimated that 310.7 thousand women and 2.8 thousand men would be diagnosed with breast cancer in the United States, potentially influenced by factors like higher obesity rates and changes in reproductive patterns such as lower fertility rates and delayed childbirth.
Additionally, the rise in product approvals by various regulatory organizations is expected to contribute to the market's growth. For instance, in February 2023, Establishment Labs Holdings Inc. completed the submission of the fourth and final part of its application to the FDA for premarket approval of Motiva Implants in the United States.
Therefore, North America is expected to hold a significant market share in the breast implant market during the forecast period.
Breast Implant Industry Overview
The breast implant market is fragmented due to the presence of small and large market players who offer a range of implants for breast augmentation, reconstruction, or other cosmetic procedures and are actively involved in enhancing their offerings in the market. Some market players are AbbVie Inc. (Allergan PLC), Establishment Labs SA, GC Aesthetics, Groupe Sebbin SAS, Laboratories Arion, Johnson & Johnson (Mentor Worldwide LLC), and Polytech Health & Aesthetics GmbH.
Breast Implants Market Leaders
-
Establishment Labs SA
-
GC Aesthetics
-
Laboratories Arion
-
Groupe Sebbin SAS
-
AbbVie Inc.
*Disclaimer: Major Players sorted in no particular order
Breast Implant Market News
- In April 2024, GC Aesthetics introduced the LUNA XT, a micro-textured anatomical breast implant, marking one of the pioneering European Medical Device Regulation (MDR)-approved products in its category.
- In September 2023, Queen's University Belfast professionals reported developing 4D-printed smart implants tailored for breast cancer patients. These implants are designed to adjust their size to fit perfectly within the individual's breast cavity, resulting in better aesthetic outcomes and an increase in confidence for those who have previously undergone breast cancer treatment. Additionally, these implants can dispense chemotherapy drugs, protecting against cancer cell recurrence in the treated area.
Breast Implants Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Incidence of Breast Cancer
- 4.2.2 Increasing Number of Breast Augmentation Procedures
- 4.2.3 Technological Advancements
-
4.3 Market Restraints
- 4.3.1 Post Complications and Risks Associated with Breast Implants
- 4.3.2 High Cost of Breast Implants
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
-
5.1 By Type
- 5.1.1 Silicone Implants
- 5.1.2 Form-stable Implants
- 5.1.3 Saline Implants
- 5.1.4 Structured Saline Implants
-
5.2 By Application
- 5.2.1 Reconstructive Surgery
- 5.2.2 Cosmetic Surgery
-
5.3 By End-user
- 5.3.1 Hospital
- 5.3.2 Cosmetology Clinic
- 5.3.3 Other End-users
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 AbbVie Inc. (Allergan PLC)
- 6.1.2 Establishment Labs SA
- 6.1.3 GC Aesthetics
- 6.1.4 Groupe Sebbin SAS
- 6.1.5 Laboratories Arion
- 6.1.6 Johnson & Johnson (Mentor Worldwide LLC )
- 6.1.7 Polytech Health & Aesthetics GmbH
- 6.1.8 Silimed
- 6.1.9 Sientra Inc.
- 6.1.10 Cereplas
- 6.1.11 HansBioMed
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityBreast Implant Industry Segmentation
As per the scope of this report, breast implants are medical devices used to augment the size of breasts, either for cosmetic applications or reconstruction purposes or to correct a congenital abnormality. The procedure involves the usage of breast implants to enhance and improve the size of the breasts.
The market is segmented by type, application, end user, and geography. By type, the market is segmented by silicone implants, form-stable implants, saline implants, and structured saline implants. By application, the market is segmented by reconstructive surgery and cosmetic surgery. By end user, the market is segmented into hospitals, cosmetology clinics, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the market size and forecasts for the breast implants market in 17 countries across the major regions. The report offers the value (USD) for the above segments.
| By Type | Silicone Implants | |
| Form-stable Implants | ||
| Saline Implants | ||
| Structured Saline Implants | ||
| By Application | Reconstructive Surgery | |
| Cosmetic Surgery | ||
| By End-user | Hospital | |
| Cosmetology Clinic | ||
| Other End-users | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Breast Implants Market Research FAQs
How big is the Breast Implant Market?
The Breast Implant Market size is expected to reach USD 2.05 billion in 2024 and grow at a CAGR of 7.77% to reach USD 2.97 billion by 2029.
What is the current Breast Implant Market size?
In 2024, the Breast Implant Market size is expected to reach USD 2.05 billion.
Who are the key players in Breast Implant Market?
Establishment Labs SA, GC Aesthetics, Laboratories Arion, Groupe Sebbin SAS and AbbVie Inc. are the major companies operating in the Breast Implant Market.
Which is the fastest growing region in Breast Implant Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Breast Implant Market?
In 2024, the North America accounts for the largest market share in Breast Implant Market.
What years does this Breast Implant Market cover, and what was the market size in 2023?
In 2023, the Breast Implant Market size was estimated at USD 1.89 billion. The report covers the Breast Implant Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Breast Implant Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Breast Implants Industry Report
The Global Breast Implants Market Report provides a comprehensive industry analysis, covering various types such as silicone implants, form-stable implants, saline implants, and structured saline implants. This market report is segmented by application into reconstructive surgery and cosmetic surgery, and by end-user into hospitals, cosmetology clinics, and other end-users. The report offers valuable market data and market segmentation insights, along with an industry overview and market review.
The market forecast includes a detailed industry outlook and market predictions, highlighting the growth rate and market trends expected in the coming years. The industry research and market research sections provide in-depth industry information and industry statistics. The report example and report pdf are available for those interested in further details.
The global market is analyzed geographically, covering regions such as North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The market value and market size are discussed, along with insights into market growth and market share. The industry reports and industry sales sections offer an extensive market overview, including market leaders and their roles in the market growth.
For those seeking more information, industry research companies have contributed to the market analysis and industry statistics provided. The market outlook and industry trends sections highlight the latest developments and future prospects in the breast implants industry. The report aims to provide a thorough understanding of the market dynamics and the factors driving market growth.
